Literature DB >> 30482793

BCAS2 is essential for hematopoietic stem and progenitor cell maintenance during zebrafish embryogenesis.

Shanshan Yu1, Tao Jiang1, Danna Jia1, Yunqiao Han1, Fei Liu1, Yuwen Huang1, Zhen Qu1, Yuntong Zhao2, Jiayi Tu1, Yuexia Lv1, Jingzhen Li1, Xuebin Hu1, Zhaojing Lu1, Shanshan Han1, Yayun Qin1, Xiliang Liu1, Shanglun Xie1, Qing K Wang1, Zhaohui Tang1, Daji Luo2,3, Mugen Liu1.   

Abstract

Hematopoietic stem and progenitor cells (HSPCs) originate from the hemogenic endothelium via the endothelial-to-hematopoietic transition, are self-renewing, and replenish all lineages of blood cells throughout life. BCAS2 (breast carcinoma amplified sequence 2) is a component of the spliceosome and is involved in multiple biological processes. However, its role in hematopoiesis remains unknown. We established a bcas2 knockout zebrafish model by using transcription activator-like effector nucleases. The bcas2 -/- zebrafish showed severe impairment of HSPCs and their derivatives during definitive hematopoiesis. We also observed significant signs of HSPC apoptosis in the caudal hematopoietic tissue of bcas2 -/- zebrafish, which may be rescued by suppression of p53. Furthermore, we show that the bcas2 deletion induces an abnormal alternative splicing of Mdm4 that predisposes cells to undergo p53-mediated apoptosis, which provides a mechanistic explanation of the deficiency observed in HSPCs. Our findings revealed a novel and vital role for BCAS2 during HSPC maintenance in zebrafish.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30482793     DOI: 10.1182/blood-2018-09-876599

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  MDM4 alternative splicing and implication in MDM4 targeted cancer therapies.

Authors:  Jin Wu; Guanting Lu; Xinjiang Wang
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

Review 2.  Splicing regulation in hematopoiesis.

Authors:  Sisi Chen; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2021-07-01       Impact factor: 3.218

3.  Prpf31 is essential for the survival and differentiation of retinal progenitor cells by modulating alternative splicing.

Authors:  Jingzhen Li; Fei Liu; Yuexia Lv; Kui Sun; Yuntong Zhao; Jamas Reilly; Yangjun Zhang; Jiayi Tu; Shanshan Yu; Xiliang Liu; Yayun Qin; Yuwen Huang; Pan Gao; Danna Jia; Xiang Chen; Yunqiao Han; Xinhua Shu; Daji Luo; Zhaohui Tang; Mugen Liu
Journal:  Nucleic Acids Res       Date:  2021-02-26       Impact factor: 16.971

4.  The spliceosome factor sart3 regulates hematopoietic stem/progenitor cell development in zebrafish through the p53 pathway.

Authors:  Yan Zhao; Mei Wu; Jing Li; Ping Meng; Jiakui Chen; Zhibin Huang; Jin Xu; Zilong Wen; Wenqing Zhang; Yiyue Zhang
Journal:  Cell Death Dis       Date:  2021-10-05       Impact factor: 8.469

5.  Negative Elongation Factor (NELF) Inhibits Premature Granulocytic Development in Zebrafish.

Authors:  Mengling Huang; Abrar Ahmed; Wei Wang; Xue Wang; Cui Ma; Haowei Jiang; Wei Li; Lili Jing
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

6.  Rod genesis driven by mafba in an nrl knockout zebrafish model with altered photoreceptor composition and progressive retinal degeneration.

Authors:  Fei Liu; Yayun Qin; Yuwen Huang; Pan Gao; Jingzhen Li; Shanshan Yu; Danna Jia; Xiang Chen; Yuexia Lv; Jiayi Tu; Kui Sun; Yunqiao Han; James Reilly; Xinhua Shu; Qunwei Lu; Zhaohui Tang; Chengqi Xu; Daji Luo; Mugen Liu
Journal:  PLoS Genet       Date:  2022-03-04       Impact factor: 5.917

7.  A splicing factor switch controls hematopoietic lineage specification of pluripotent stem cells.

Authors:  Yapu Li; Ding Wang; Hongtao Wang; Xin Huang; Yuqi Wen; BingRui Wang; Changlu Xu; Jie Gao; Jinhua Liu; Jingyuan Tong; Mengge Wang; Pei Su; Sirui Ren; Feng Ma; Hong-Dong Li; Emery H Bresnick; Jiaxi Zhou; Lihong Shi
Journal:  EMBO Rep       Date:  2020-12-15       Impact factor: 9.071

Review 8.  Alternative Splicing in Myeloid Malignancies.

Authors:  Carmelo Gurnari; Simona Pagliuca; Valeria Visconte
Journal:  Biomedicines       Date:  2021-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.